The Food and Drug Administration on Friday approved an extended-release version of the narcotic painkiller hydrocodone despite a recommendation by its advisory committee that the drug should be rejected because of its potential for abuse.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303615304579158041808437498.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303615304579158041808437498.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento